September 6, 2012 -- YTB International Inc. announced that it has ended merger discussions with LTS Neutraceuticals Inc. In a regulatory filing, YTB said that it "has determined that, after further analysis and consideration, a merger with LTS Neutraceuticals Inc. is not in the best long-term interests of the stockholders and would no enhance the strategic or competitive stance of the company."
YTB also announced that executive vice president and chairman J. Scott Tomer resigned his posts in the company as of August 31. A new chairman will be appointed at YTB's next board meeting.